Photoprotective behaviours in inflammatory bowel disease patients on azathioprine and TNF-α inhibitors

被引：0
|
作者：
Gallagher, C. [1 ,2 ]
Ridge, A. [3 ]
Tobin, A. M. [1 ,4 ]
Kevans, D. [5 ]
McNamara, D. [1 ,6 ]
机构：
[1] Adelaide & Meath Hosp, Dublin, Ireland
[2] Natl Childrens Hosp, Dept Clin Med, Dublin, Ireland
[3] Trinity Coll Dublin, Dept Clin Med, Dublin, Ireland
[4] Natl Childrens Hosp, Dept Dermatol, Dublin, Ireland
[5] St James Hosp, Coll Dublin, Dept Gastroenterol, Dublin, Ireland
[6] Natl Childrens Hosp, Dept Clin Med & Gastroenterol, Dublin, Ireland
来源：
JOURNAL OF CROHNS & COLITIS | 2017年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P184
引用
收藏
页码：S169 / S170
页数：2
相关论文
共 50 条
  • [1] Retesting for latent tuberculosis in patients with inflammatory bowel disease treated with TNF-α inhibitors
    Papay, P.
    Primas, C.
    Eser, A.
    Novacek, G.
    Winkler, S.
    Frantal, S.
    Angelberger, S.
    Mikulits, A.
    Dejaco, C.
    Kazemi-Shirazi, L.
    Vogelsang, H.
    Reinisch, W.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 36 (09) : 858 - 865
  • [2] TNF-α INHIBITORS AND RISK OF TYPE 2 DIABETES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Villumsen, Marie
    Andersen, Nynne Nyboe
    Jess, Tine
    Allin, Kristine
    [J]. GASTROENTEROLOGY, 2019, 156 (06) : S879 - S879
  • [3] Spondyloarthropathy in inflammatory bowel disease patients on TNF inhibitors
    Subramaniam, K.
    Tymms, K.
    Shadbolt, B.
    Pavli, P.
    [J]. INTERNAL MEDICINE JOURNAL, 2015, 45 (11) : 1154 - 1160
  • [4] Body mass index and response to TNF-α inhibitors in inflammatory bowel disease
    Nordin, F.
    Shadbolt, B.
    Subramaniam, K.
    [J]. JOURNAL OF CROHNS & COLITIS, 2020, 14 : S453 - S453
  • [5] Photoprotective behaviours in an Irish at-risk inflammatory bowel disease population
    Gallagher, C.
    Ridge, A.
    Kevans, D.
    McNamara, D.
    Tobin, A-M
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2017, 177 : 148 - 148
  • [6] Treatment Failure of TNF-α Inhibitors in Obese Patients With Inflammatory Bowel Disease-A Cohort Study
    Madsen, Kenneth Gronkjaer
    Pottegard, Anton
    Hallas, Jesper
    Kjeldsen, Jens
    [J]. INFLAMMATORY BOWEL DISEASES, 2018, 24 (12) : 2628 - 2633
  • [7] Genetic polymorphisms of tumour necrosis factor alpha (TNF-α) promoter gene and response to TNF-α inhibitors in Spanish patients with inflammatory bowel disease
    Lopez-Hernandez, R.
    Valdes, M.
    Campillo, J. A.
    Martinez-Garcia, P.
    Salama, H.
    Salgado, G.
    Boix, F.
    Moya-Quiles, M. R.
    Minguela, A.
    Sanchez-Torres, A.
    Miras, M.
    Garcia, A.
    Carballo, F.
    Alvarez-Lopez, M. R.
    Muro, M.
    [J]. INTERNATIONAL JOURNAL OF IMMUNOGENETICS, 2014, 41 (01) : 63 - 68
  • [8] Targeting TNF-α for the treatment of inflammatory bowel disease
    Billiet, Thomas
    Rutgeerts, Paul
    Ferrante, Marc
    Van Assche, Gert
    Vermeire, Severine
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2014, 14 (01) : 75 - 101
  • [9] Mycophenolate mofetil is a valid option in patients with inflammatory bowel disease resistant to TNF-α inhibitors and conventional immunosuppressants
    Macaluso, Fabio Salvatore
    Maida, Marcello
    Renna, Sara
    Orlando, Emanuele
    Affronti, Marco
    Sapienza, Chiara
    Dimarco, Mariangela
    Orlando, Rosalba
    Rizzuto, Giulia
    Cottone, Mario
    Orlando, Ambrogio
    [J]. DIGESTIVE AND LIVER DISEASE, 2017, 49 (02) : 157 - 162
  • [10] Outcome of inflammatory bowel disease patients treated with TNF-α inhibitors: two-year follow-up
    Lehtola, Erika
    Haapamaki, Johanna
    Farkkila, Martti A.
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2016, 51 (12) : 1476 - 1481
12345